Cited by 370Blood Coagulation and Thrombosis MechanismsReceptor Mechanisms and SignalingProtease and Inhibitor Mechanisms

Structure, function and pathophysiology of protease activated receptors

Adams, Mark N., Ramachandran, Rithwik, Yau, Mei-Kwan, Suen, Jacky Y., Fairlie, David P., Hollenberg, Morley D., Hooper, John D.·2011·Pharmacology & Therapeutics

Abstract

Discovered in the 1990s, protease activated receptors(1) (PARs) are membrane-spanning cell surface proteins that belong to the G protein coupled receptor (GPCR) family. A defining feature of these receptors is their irreversible activation by proteases; mainly serine. Proteolytic agonists remove the PAR extracellular amino terminal pro-domain to expose a new amino terminus, or tethered ligand, that binds intramolecularly to induce intracellular signal transduction via a number of molecular pathways that regulate a variety of cellular responses. By these mechanisms PARs function as cell surface sensors of extracellular and cell surface associated proteases, contributing extensively to regulation of homeostasis, as well as to dysfunctional responses required for progression of a number of diseases. This review examines common and distinguishing structural features of PARs, mechanisms of receptor activation, trafficking and signal termination, and discusses the physiological and pathological roles of these receptors and emerging approaches for modulating PAR-mediated signaling in disease.

Integrity signals

Registry

Crossref · 10.1016/j.pharmthera.2011.01.003

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The functional consequence of a particular protease activating PARs depends on which PAR is activated and what its downstream signaling pathways are, including whether canonical or biased signaling pathways are initiated.

    “The functional consequence of a particular protease activating PARs depends on which PAR is activated and what its downstream signaling pathways are, including whether canonical or biased signaling pathways are initiated.136,137”

The citation lists haven’t been fetched yet

References 517 · Cited by 370

Authors
Adams, M. N., Ramachandran, R., Yau, M.-K., Suen, J. Y., Fairlie, D. P., Hollenberg, M. D., & Hooper, J. D.
Affiliations
  • Queensland University of Technology (AU)
  • University of Calgary (CA)
  • The University of Queensland (AU)
  • Mater Research (AU)
Corresponding author
Hooper, John D.
Venue
Pharmacology & Therapeutics
Publisher
Elsevier BV
Published
2011-06
Volume
130
Issue
3
Pages
248-282
ISSN
0163-7258 (ISSN-L)
OpenAlex
W2056362028
Cited by
370
References
517
Citations by year
2026: 8 · 2025: 9 · 2024: 18 · 2023: 19 · 2022: 25 · 2021: 29 · 2020: 25 · 2019: 28 · 2018: 20 · 2017: 31 · 2016: 32 · 2015: 28 · 2014: 34 · 2013: 26 · 2012: 28
FWCI
4.01
Type
journal article
Language
en
Open access
closed
Locations
  • Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
  • Scholarship@Western (Western University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Keywords
protease-activated receptors, G protein-coupled receptors, serine protease, receptor activation, tethered ligand, signal transduction, receptor trafficking, signal termination, receptor structure, disease pathophysiology
MeSH terms
Amino Acid Sequence, Animals, Cell Membrane, Clinical Trials as Topic, Coronary Artery Disease, Humans, Molecular Sequence Data, Protein Binding, Signal Transduction, Receptors, Proteinase-Activated

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review